biotech · Advanced Solid Tumor · Sjogren's Disease · CGEM
Cullinan Therapeutics
Cullinan Therapeutics clinical programs — 13 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Dyer St, Providence, Rhode Island 02903, US
- Founded
- 2017
- Employees
- 7
- Programs
- 16
- Drugs
- 14
- Patents
- 3
Cullinan Therapeutics projects
13 ClinicalTrials.gov programs sponsored by Cullinan Therapeutics.
Cullinan Therapeutics has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
CLN-049
Cullinan Therapeutics
Relapsed/Refractory Acute Myeloid Leukemia (AML)
1 trial -
CLN-049-002
Cullinan Therapeutics
Acute Myeloid Leukemia (AML) with Measurable Residual Disease (MRD)
1 trial -
CLN-617
Cullinan Therapeutics
Advanced Solid Tumor
1 trial -
CLN-619
Cullinan Therapeutics
Advanced Solid Tumor
1 trial -
CLN-619
Cullinan Therapeutics
Multiple Myeloma
1 trial -
CLN-619-001
Cullinan Therapeutics
Solid tumors, Non-Small Cell Lung Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer, breast cancer, gastrointestinal cancer
1 trial -
CLN-978
Cullinan Therapeutics
SLE
1 trial -
CLN-978
Cullinan Therapeutics
NHL
1 trial -
CLN-978
Cullinan Therapeutics
Rheumatoid Arthritis (RA
1 trial -
CLN-978
Cullinan Therapeutics
Sjögren
1 trial -
CLN-978-RA-101
Cullinan Therapeutics
Treatment-Refractory Rheumatoid Arthritis
1 trial -
CLN-978-SJ-101
Cullinan Therapeutics
Sjogren's Disease
1 trial -
CLN-978-SL-101
Cullinan Therapeutics
Systemic Lupus Erythematosus
1 trial
Frequently asked questions
How many clinical projects does Cullinan Therapeutics have?
13 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.